Total Payments
$1,102
2018 Payments
$83.24
Companies
13
Transactions
86
Medicare Patients
1,076
Medicare Billing
$94,560
Payment Breakdown by Category
Food & Beverage$1,096 (99.5%)
Education$6.02 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,096 | 85 | 99.5% |
| Education | $6.02 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $249.16 | 17 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $199.94 | 12 | $0 (2018) |
| PFIZER INC. | $171.51 | 16 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $145.97 | 18 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $145.28 | 9 | $0 (2017) |
| Daiichi Sankyo Inc. | $57.69 | 4 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $34.11 | 2 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $32.15 | 2 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $17.71 | 1 | $0 (2017) |
| Allergan Inc. | $14.29 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $83.24 | 6 | AstraZeneca Pharmaceuticals LP ($30.66) |
| 2017 | $1,019 | 80 | Janssen Pharmaceuticals, Inc ($219.34) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2018 | Purdue Pharma L.P. | SYMPROIC (Drug), BUTRANS | Food and Beverage | Cash or cash equivalent | $11.64 | General |
| Category: CONSTIPATION | ||||||
| 01/09/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Respiratory | ||||||
| 01/08/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: DIABETES | ||||||
| 12/07/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/06/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/05/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), INVOKAMET, XARELTO | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Education | In-kind items and services | $6.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: VACCINE | ||||||
| 11/13/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2017 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/06/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 11/02/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 11/01/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 10/18/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2017 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN | Food and Beverage | Cash or cash equivalent | $7.43 | General |
| Category: Osteoarthritis | ||||||
| 10/03/2017 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN | Food and Beverage | Cash or cash equivalent | $2.38 | General |
| Category: Osteoarthritis | ||||||
| 10/02/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 639 | 818 | $67,328 | $45,994 |
| 2022 | 11 | 375 | 582 | $123,320 | $40,066 |
| 2021 | 3 | 62 | 97 | $80,697 | $8,501 |
Total Patients
1,076
Total Services
1,497
Medicare Billing
$94,560
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 148 | 153 | $20,290 | $14,382 | 70.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 234 | $18,482 | $13,823 | 74.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 108 | 114 | $13,239 | $9,736 | 73.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $3,127 | $2,120 | 67.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 19 | $2,250 | $1,614 | 71.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 25 | $2,557 | $1,415 | 55.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 193 | 222 | $5,348 | $1,379 | 25.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 22 | $1,064 | $796.28 | 74.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $970.44 | $728.74 | 75.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 107 | 248 | $43,374 | $13,104 | 30.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 50 | 50 | $20,654 | $7,393 | 35.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 49 | $18,513 | $3,583 | 19.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 45 | 45 | $5,410 | $3,551 | 65.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 32 | $6,083 | $3,158 | 51.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $8,904 | $2,751 | 30.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 25 | 60 | $2,389 | $1,658 | 69.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 31 | 31 | $8,687 | $1,634 | 18.8% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 13 | 14 | $1,870 | $1,428 | 76.4% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 16 | 20 | $4,375 | $1,097 | 25.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $3,061 | $709.92 | 23.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 66 | $48,913 | $5,159 | 10.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $17,274 | $1,817 | 10.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 19 | 19 | $14,510 | $1,524 | 10.5% |
About Dr. Darl Bell, MD
Dr. Darl Bell, MD is a Internal Medicine healthcare provider based in Atoka, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275538977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darl Bell, MD has received a total of $1,102 in payments from pharmaceutical and medical device companies, with $83.24 received in 2018. These payments were reported across 86 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,096).
As a Medicare-enrolled provider, Bell has provided services to 1,076 Medicare beneficiaries, totaling 1,497 services with total Medicare billing of $94,560. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Atoka, TN
- Active Since 06/17/2005
- Last Updated 11/03/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275538977
Products in Payments
- XARELTO (Drug) $143.76
- LYRICA (Drug) $119.52
- FARXIGA (Drug) $116.94
- JARDIANCE (Drug) $113.34
- INVOKANA (Drug) $105.40
- JANUVIA (Drug) $67.68
- BEVESPI AEROSPHERE (Drug) $56.10
- VIAGRA (Drug) $51.99
- XIFAXAN (Drug) $32.15
- TRADJENTA (Drug) $31.94
- Movantik (Drug) $31.48
- INJECTAFER (Drug) $26.21
- ZOSTAVAX (Biological) $23.95
- ASMANEX (Drug) $22.56
- BELSOMRA (Drug) $19.96
- ZURAMPIC (Drug) $17.71
- TOUJEO (Drug) $17.07
- SOLIQUA (Drug) $17.04
- LINZESS (Drug) $14.29
- MOVANTIK (Drug) $13.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.